PolyNovo (ASX:PNV) said its monthly sales reached a record AU$10.1 million in November, up from AU$8.8 million a year earlier, according to a Monday filing with the Australian bourse.

US sales came in at AU$7 million, while sales from the rest of the world stood at AU$3.1 million.

Total group revenue for the month, including income from the US Biomedical Advanced Research Development Authority, was AU$11 million, the filing said. Year to date, group revenue climbed over 25% year on year to AU$49.6 million in November.

The medical device maker's shares were up nearly 6% in recent Monday trade.